Loading…

The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren’s syndrome

Background: Increased levels of B lymphocyte stimulator (BLyS) have been detected in serum from patients with systemic lupus erythematosus and rheumatoid arthritis. Objective: To determine the level of BLyS in serum from patients with primary’s Sjögren’s syndrome (SS), another autoimmune disease in...

Full description

Saved in:
Bibliographic Details
Published in:Annals of the rheumatic diseases 2003-02, Vol.62 (2), p.168-171
Main Authors: Mariette, X, Roux, S, Zhang, J, Bengoufa, D, Lavie, F, Zhou, T, Kimberly, R
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Increased levels of B lymphocyte stimulator (BLyS) have been detected in serum from patients with systemic lupus erythematosus and rheumatoid arthritis. Objective: To determine the level of BLyS in serum from patients with primary’s Sjögren’s syndrome (SS), another autoimmune disease in which B cell activation is high. Methods: Serum samples from 49 patients with primary SS according to the revised European criteria were assayed for BLyS, quantitative immunoglobulins, and autoantibody levels and compared with samples from 47 healthy control subjects. Results: The median level of BLyS was 5.99 ng/ml (25th-75th centile range 3.20–8.93 ng/ml) in SS v 2.49 ng/ml (25th-75th centile range 1.96–2.96 ng/ml) in healthy controls (p
ISSN:0003-4967
1468-2060
DOI:10.1136/ard.62.2.168